Peptide MedixCartalax
Ala-Glu-Asp synthetic bioregulator tripeptide studied in cartilage models
Tap I use this — we'll set up your dose, reminders & journey in 30 seconds.
Cartalax is a synthetic tripeptide with the sequence Ala-Glu-Asp (AED), one of the short peptides developed within the bioregulator research programme associated with Vladimir Khavinson at the St Petersburg Institute of Bioregulation and Gerontology. Within that programme it is designated the cartilage and connective-tissue bioregulator, the synthetic counterpart to Sigumir, which is a peptide fraction extracted from animal cartilage. The bioregulator hypothesis holds that very short, tissue-associated peptides act at the level of gene expression rather than through classical receptor signalling. Cartalax is one of the sequences most often used to test that idea in cartilage and chondrocyte systems. Supplied as lyophilized powder in a sealed 20 mg vial with a lot-matched certificate of analysis. It is for research use only and not a drug, supplement or consumer product.
- Peptide
- Cartalax
- Strength
- 20 mg
- Package
- 20 mg
- Purity
- ≥98% by HPLC
- Form
- vial
